Spine News and Research

RSS

Cellular and subcellular effects of PACE technology presented

SANUWAVE Health, Inc., (www.sanuwave.com), an emerging medical technology company focused on the development and commercialization of non-invasive, biological response activating devices in the regenerative medicine area, announced that the cellular and subcellular effects of PACE™ technology were described during a lecture presented this past weekend.

15 Dec 2009

NAMS recommends women to discuss osteoporosis with their OB/GYNs

According to a new survey distributed by The North American Menopause Society (NAMS), while 98 percent of women who participated consider bone strength to be an important health concern, nearly half (45 percent) of these women reported that osteoporosis was not addressed during their last routine OB/GYN visit, and more than a quarter (26.4 percent) of women surveyed have never discussed osteoporosis with their OB/GYN.

14 Dec 2009

Proteins from catfish venom glands could accelerate wound healing in humans

Lest anyone have concerns about attacks of killer catfish, rest assured that, at least in North America, these finned fatales use their venom mainly to defend themselves against predatory fish, though they can inflict a painful sting that many fishermen have suffered. In other parts of the world, some catfish do have extremely toxic venoms that can be deadly to humans.

11 Dec 2009

New data suggests bisphosphonate drug may play a role in reducing recurrent breast cancer

Bisphosphonates are routinely given to women with postmenopausal breast cancer, but new data suggests that these agents may play a role in reducing recurrent breast cancer as well.

11 Dec 2009

Fulvestrant 500 mg reduces risk of disease progression in women with metastatic breast cancer

AstraZeneca (NYSE: AZN) today announced that data from a Phase III study of postmenopausal women with hormone receptor-positive advanced breast cancer presented at the San Antonio Breast Cancer Symposium (Abstract 25) showed treatment with fulvestrant (FASLODEX) 500 mg reduced the risk of disease progression (assessed as time to progression (TTP)) by 20%

11 Dec 2009

St. Luke's Hospital acquires computer-assisted surgery system from BrainLAB

BrainLAB, a manufacturer of software-driven systems for targeted, less-invasive medical treatments, announced today that St. Luke's Hospital in Cedar Rapids, Iowa, has acquired VectorVision® flex, a powerful computer-assisted surgery (CAS) system featuring Digital Lightbox© with TraumaCad(TM), a pre-operative planning and digital templating software solution.

9 Dec 2009

Osteologix to file an European Marketing Application for its NB S101 strontium therapy

Osteologix Inc. announced today that the company anticipates that it will be prepared to file a marketing application in 2011 in the European Union for its proprietary second-generation strontium therapy, NB S101 (strontium malonate). If successful, this will be Osteologix' first marketing approval of NB S101 for the treatment of postmenopausal osteoporosis.

9 Dec 2009

Global Health Partner starts up business for obesity treatment in Prague

Global Health Partner has started up a business for the treatment of obesity in Prague, and the first obesity operations have now been performed.

9 Dec 2009

Tips to prevent foot injuries from high heel shoes

High heels, offer a height advantage to shorter women and can also make the calves and legs appear shapelier...but that’s where the benefits end. Most women sooner or later, develop a love/hate relationship with their collection of shoes, that is to say they are often attractive yet painful to wear. As we approach the Christmas party season ‘what shoes to wear’ can become a real concern.

9 Dec 2009

Ontario chiropractors offer tips to help ward off common seasonal injuries

With the season's first winter storm looming, Ontarians can expect to get quite a workout clearing the driveway - especially when you consider that a single shovelful of snow weighs 5 to 7 pounds. Improper shoveling can lead to minor strains and sore muscles, and can also cause more serious injuries.

9 Dec 2009

On-X Life Technologies, Cleveland Clinic enter into an exclusive worldwide license agreement

Austin-based On-X® Life Technologies, Inc., manufacturers of the On-X® Prosthetic Heart Valve, announced today that it has entered into an exclusive worldwide license with the Cleveland Clinic for a system of products intended to improve and simplify the replacement of damaged or severed mitral valve chordae.

9 Dec 2009

CDC awards Case Western Reserve University School of Medicine $19.7M for TB research

John L. Johnson, M.D., Professor of Medicine at Case Western Reserve University School of Medicine and pulmonologist at University Hospitals Case Medical Center has been awarded a 10 year, $19.7M contract from the U.S. Centers for Disease Control and Prevention (CDC) as an international clinical trials site for the Tuberculosis Trials Consortium (TBTC).

9 Dec 2009

Spine system: A new technique to treat lower back pain

Using a branch of science that crosses disciplines to study complex problems, a Michigan State University researcher is introducing a new way to understand and treat lower back pain, a condition affecting more than 40 million Americans and costing billions of dollars each year.

9 Dec 2009

CDC awards $19.7 million contract to study new drugs for tuberculosis treatment

8 Dec 2009

Applied Spine Technologies: Two Stabilimax surgeries performed in South Africa

Applied Spine Technologies announced today the first two Stabilimax surgeries performed outside of the United States. The surgeries were performed in Johannesburg, South Africa, by Ajay Maharaj, MD, at Sunninghill Hospital. The Stabilimax Dynamic Spine System is currently part of an IDE multi-center, randomized, controlled clinical trial in the U.S.

8 Dec 2009

The National Fragile X Foundation awards $100,000 grant for study of minocycline in FXS children

The National Fragile X Foundation has awarded a translational research seed grant of $100,000 to Dr. Randi J. Hagerman at the UC Davis M.I.N.D. Institute in California for a study of minocycline in the treatment of children with fragile X syndrome (FXS). Hagerman is an internationally recognized clinician and clinical researcher on FXS, the most common cause of inherited mental impairment.

8 Dec 2009

Orthofix International announces the launch of its FUSION Lateral OA Brace

Orthofix International announced today that its sports medicine division, BREG, has expanded its successful line of FUSION® functional knee braces by introducing the FUSION® Lateral OA Brace, which features an ultra-thin low-profile hinge designed for individuals suffering from lateral compartment osteoarthritis (OA).

4 Dec 2009

FDA approves St. Jude Medical's Penta surgical lead for neurostimulation therapy

St. Jude Medical, Inc. today announced the U.S. Food and Drug Administration (FDA) approval and U.S. market introduction of its new Penta™ surgical lead for neurostimulation therapy. Unveiled at the annual North American Neuromodulation Society meeting, the Penta lead is the first of its kind, featuring the smallest electrodes in the market arranged in five columns.

4 Dec 2009

Severity of injury has the most effect on workers' compensation

The severity of injury and level of impairment -- not the workers' legal fees -- have the most effect on payout for workers' compensation claims among Illinois construction workers, researchers at the University of Illinois at Chicago School of Public Health have found.

4 Dec 2009

FDA approves St. Jude Medical's MultiSteering Technology software for optimizing neurostimulation therapy

St. Jude Medical, Inc. today announced U.S. Food and Drug Administration (FDA) approval of its next-generation MultiSteering Technology software for Rapid Programmer™, a programming platform used to optimize neurostimulation therapy for chronic pain patients.

4 Dec 2009

Spine News and Research

Cellular and subcellular effects of PACE technology presented

NAMS recommends women to discuss osteoporosis with their OB/GYNs

Proteins from catfish venom glands could accelerate wound healing in humans

New data suggests bisphosphonate drug may play a role in reducing recurrent breast cancer

Fulvestrant 500 mg reduces risk of disease progression in women with metastatic breast cancer

St. Luke's Hospital acquires computer-assisted surgery system from BrainLAB

Osteologix to file an European Marketing Application for its NB S101 strontium therapy

Global Health Partner starts up business for obesity treatment in Prague

Tips to prevent foot injuries from high heel shoes

Ontario chiropractors offer tips to help ward off common seasonal injuries

On-X Life Technologies, Cleveland Clinic enter into an exclusive worldwide license agreement

CDC awards Case Western Reserve University School of Medicine $19.7M for TB research

Spine system: A new technique to treat lower back pain

CDC awards $19.7 million contract to study new drugs for tuberculosis treatment

Applied Spine Technologies: Two Stabilimax surgeries performed in South Africa

The National Fragile X Foundation awards $100,000 grant for study of minocycline in FXS children

Orthofix International announces the launch of its FUSION Lateral OA Brace

FDA approves St. Jude Medical's Penta surgical lead for neurostimulation therapy

Severity of injury has the most effect on workers' compensation

FDA approves St. Jude Medical's MultiSteering Technology software for optimizing neurostimulation therapy

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News